| Pharmaco-economics in Dutch decision-making |
| Monday, 06 July 2009 00:00 |
|
Dutch health-care decision-making increasingly incorporates cost-effectiveness as an explicit factor, both at the national policy level as by healthcare insurance companies and in the development of professional treatment guidelines. We have a good overview of current requirements and future directions to guide our clients to successful market access for their products. Contact us for further information. |


